Detection of Celiac Disease in Patients With Hypothyroidism

NCT01862510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2014-12-08

No results posted yet for this study

Summary

The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with hypothyroidism that should prompt serologic testing for celiac disease.

Conditions

Sponsors & Collaborators

  • University of Vermont

    lead OTHER

Principal Investigators

  • Richard Zubarik, MD · University of Vermont

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01862510 on ClinicalTrials.gov